Profound Medical Corp. is a leading Canadian medical technology company headquartered in Mississauga that specializes in developing advanced therapeutic solutions for prostate cancer. The company's flagship TULSA-PRO system uniquely integrates real-time MRI imaging with ultrasound technology, enabling precise targeting of prostate tissue while safeguarding adjacent healthy structures. Committed to enhancing patient outcomes through minimally invasive procedures, Profound is at the forefront of innovation in the urology market. With ambitions to expand its global reach, the company is poised to elevate the standard of care through strategic research initiatives and partnerships.